assembly_id	genome_id	genome_def	crispr_array_locus_merge	crispr_array_location_merge	crispr_locus_id	crispr_pred_method	array_in_prot	prot_within_array_20000	prot_in_genome	crispr_type_by_cas_prot	consensus_repeat	repeat_length	self-targeting_spacer_number	self-targeting_target_number	spacer_location	protospacer_location	repeat_type	spacer_locus_num	spacer_num	correct_crispr_type	genome_cas_prots	unknown_protein_around_crispr	L10	L10_domain	L9	L9_domain	L8	L8_domain	L7	L7_domain	L6	L6_domain	L5	L5_domain	L4	L4_domain	L3	L3_domain	L2	L2_domain	L1	L1_domain	R1	R1_domain	R2	R2_domain	R3	R3_domain	R4	R4_domain	R5	R5_domain	R6	R6_domain	R7	R7_domain	R8	R8_domain	R9	R9_domain	R10	R10_domain
GCF_002356115.1_ASM235611v1	NZ_AP014836	Candidatus Nitrosoglobus terrae strain TAO100	1	1867326-1871807	1,1,1	CRISPRCasFinder,CRT,PILER-CR	no	cas2,cas1,cas5,cas7,cas6e,cse2gr11,cas8e,cas3	cas14j,DEDDh,RT,csa3,cas3,c2c9_V-U4,DinG,cas2,cas1,cas5,cas7,cas6e,cse2gr11,cas8e	Type I-E	AGAAACACCCCCACGGGCGTGGGGAAGAC,GAAACACCCCCACGGGCGTGGGGAAGAC,GAAACACCCCCACGGGCGTGGGGAAGAC	29,28,28	2	2	1870893-1870924|1870893-1870925	NZ_AP014836.1_885412-885381|NZ_AP014836.1_885412-885380	I-B,III-A,III-B:I-B,III-A,III-B:I-B,III-A,III-B	73,73,54	73	TypeI-E	cas14j,DEDDh,RT,csa3,cas3,c2c9_V-U4,DinG,cas2,cas1,cas5,cas7,cas6e,cse2gr11,cas8e	NA|89aa|up_7|NZ_AP014836.1_1850903_1851170_+,NA|53aa|down_8|NZ_AP014836.1_1880284_1880443_+	NA|96aa|up_9|NZ_AP014836.1_1850197_1850485_+	TIGR02384, Putative_antitoxin_RelB, addiction module antitoxin, RelB/DinJ family	NA|108aa|up_8|NZ_AP014836.1_1850481_1850805_+	pfam15738, YafQ_toxin, Bacterial toxin of type II toxin-antitoxin system, YafQ	NA|89aa|up_7|NZ_AP014836.1_1850903_1851170_+	NA	NA|139aa|up_6|NZ_AP014836.1_1851153_1851570_+	COG5611, COG5611, Predicted nucleic-acid-binding protein, contains PIN domain [General function prediction only]	NA|406aa|up_5|NZ_AP014836.1_1851751_1852969_+	COG1373, COG1373, Predicted ATPase (AAA+ superfamily) [General function prediction only]	NA|1033aa|up_4|NZ_AP014836.1_1853026_1856125_+	COG0610, COG0610, Type I site-specific restriction-modification system, R (restriction) subunit and related helicases [Defense mechanisms]	NA|1365aa|up_3|NZ_AP014836.1_1856381_1860476_-	TIGR02607, Virulence-associated_protein_I, addiction module antidote protein, HigA family	NA|526aa|up_2|NZ_AP014836.1_1861076_1862654_-	PRK00074, guaA, GMP synthase; Reviewed	NA|489aa|up_1|NZ_AP014836.1_1862650_1864117_-	PRK05567, PRK05567, inosine 5'-monophosphate dehydrogenase; Reviewed	NA|448aa|up_0|NZ_AP014836.1_1864216_1865560_+	PRK00286, xseA, exodeoxyribonuclease VII large subunit; Reviewed	cas2|97aa|down_0|NZ_AP014836.1_1871912_1872203_-	TIGR01873, CRISPR-associated_endoribonuclease_Cas2, CRISPR-associated endoribonuclease Cas2, subtype I-E/ECOLI	cas1|292aa|down_1|NZ_AP014836.1_1872180_1873056_-	TIGR03638, cas1_ECOLI, CRISPR-associated endonuclease Cas1, subtype I-E/ECOLI	cas5|234aa|down_2|NZ_AP014836.1_1873061_1873763_-	TIGR01868, hypothetical_protein, CRISPR-associated protein Cas5/CasD, subtype I-E/ECOLI	cas7|343aa|down_3|NZ_AP014836.1_1873772_1874801_-	pfam09344, Cas_CT1975, CT1975-like protein	cas6e|219aa|down_4|NZ_AP014836.1_1874814_1875471_-	cd09727, Cas6_I-E, CRISPR/Cas system-associated RAMP superfamily protein Cas6e	cse2gr11|181aa|down_5|NZ_AP014836.1_1875467_1876010_-	cd09731, Cse2_I-E, CRISPR/Cas system-associated protein Cse2	cas8e|519aa|down_6|NZ_AP014836.1_1876027_1877584_-	cd09729, Cse1_I-E, CRISPR/Cas system-associated protein Cse1	cas3|874aa|down_7|NZ_AP014836.1_1877596_1880218_-	PRK09694, PRK09694, CRISPR-associated helicase/endonuclease Cas3	NA|53aa|down_8|NZ_AP014836.1_1880284_1880443_+	NA	NA|994aa|down_9|NZ_AP014836.1_1880507_1883489_-	PRK09776, PRK09776, putative diguanylate cyclase; Provisional
